DSAM 13D 060704

Company

Inhibitor Therapeutics, Inc.

Filed

June 7, 2004

Accession Number

0001185185-04-000105

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →